Germany
· Delayed Price · Currency is EUR Thermo Fisher Scientific Statistics
Total Valuation
FRA:TN8 has a market cap or net worth of EUR 140.56 billion. The enterprise value is 165.72 billion.
| Market Cap | 140.56B |
| Enterprise Value | 165.72B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Mar 14, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.36% |
| Shares Change (QoQ) | -1.04% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 376.70M |
Valuation Ratios
The trailing PE ratio is 23.37.
| PE Ratio | 23.37 |
| Forward PE | n/a |
| PS Ratio | 3.55 |
| PB Ratio | 3.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.66, with an EV/FCF ratio of 26.70.
| EV / Earnings | 27.56 |
| EV / Sales | 4.36 |
| EV / EBITDA | 16.66 |
| EV / EBIT | 24.05 |
| EV / FCF | 26.70 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.77 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 3.03 |
| Debt / FCF | 5.08 |
| Interest Coverage | 5.90 |
Financial Efficiency
Return on equity (ROE) is 13.70% and return on invested capital (ROIC) is 5.95%.
| Return on Equity (ROE) | 13.70% |
| Return on Assets (ROA) | 5.00% |
| Return on Invested Capital (ROIC) | 5.95% |
| Return on Capital Employed (ROCE) | 9.14% |
| Revenue Per Employee | 316,827 |
| Profits Per Employee | 48,110 |
| Employee Count | 125,000 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 4.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.78% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -30.78% |
| 50-Day Moving Average | 448.12 |
| 200-Day Moving Average | 511.13 |
| Relative Strength Index (RSI) | 36.62 |
| Average Volume (20 Days) | 224 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.12 |
Income Statement
In the last 12 months, FRA:TN8 had revenue of EUR 39.60 billion and earned 6.01 billion in profits. Earnings per share was 15.75.
| Revenue | 39.60B |
| Gross Profit | 16.38B |
| Operating Income | 7.25B |
| Pretax Income | 6.45B |
| Net Income | 6.01B |
| EBITDA | 9.99B |
| EBIT | 7.25B |
| Earnings Per Share (EPS) | 15.75 |
Balance Sheet
The company has 5.49 billion in cash and 31.56 billion in debt, giving a net cash position of -26.07 billion.
| Cash & Cash Equivalents | 5.49B |
| Total Debt | 31.56B |
| Net Cash | -26.07B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 45.68B |
| Book Value Per Share | 120.55 |
| Working Capital | 9.42B |
Cash Flow
In the last 12 months, operating cash flow was 7.51 billion and capital expenditures -1.31 billion, giving a free cash flow of 6.21 billion.
| Operating Cash Flow | 7.51B |
| Capital Expenditures | -1.31B |
| Free Cash Flow | 6.21B |
| FCF Per Share | n/a |
Margins
Gross margin is 41.37%, with operating and profit margins of 18.30% and 15.18%.
| Gross Margin | 41.37% |
| Operating Margin | 18.30% |
| Pretax Margin | 16.29% |
| Profit Margin | 15.18% |
| EBITDA Margin | 25.24% |
| EBIT Margin | 18.30% |
| FCF Margin | 15.67% |
Dividends & Yields
This stock pays an annual dividend of 1.48, which amounts to a dividend yield of 0.40%.
| Dividend Per Share | 1.48 |
| Dividend Yield | 0.40% |
| Dividend Growth (YoY) | 11.49% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 9.16% |
| Buyback Yield | 1.36% |
| Shareholder Yield | 1.75% |
| Earnings Yield | 4.28% |
| FCF Yield | 4.42% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |